BNP Paribas upgraded shares of Koninklijke Philips (NYSE:PHG – Free Report) from an underperform rating to a neutral rating in a research report report published on Tuesday, MarketBeat.com reports.
Several other equities analysts have also weighed in on PHG. UBS Group upgraded shares of Koninklijke Philips from a sell rating to a neutral rating in a research report on Tuesday, April 30th. JPMorgan Chase & Co. upgraded shares of Koninklijke Philips from an underweight rating to a neutral rating in a report on Tuesday, April 30th. Finally, StockNews.com upgraded shares of Koninklijke Philips from a buy rating to a strong-buy rating in a research report on Thursday, February 8th. Three investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Koninklijke Philips currently has an average rating of Moderate Buy and an average target price of $19.00.
View Our Latest Analysis on PHG
Koninklijke Philips Price Performance
Hedge Funds Weigh In On Koninklijke Philips
Hedge funds have recently added to or reduced their stakes in the company. Principal Securities Inc. bought a new stake in Koninklijke Philips in the fourth quarter worth approximately $27,000. Allspring Global Investments Holdings LLC acquired a new position in Koninklijke Philips during the first quarter worth $40,000. Fifth Third Bancorp raised its holdings in Koninklijke Philips by 34.4% during the first quarter. Fifth Third Bancorp now owns 3,008 shares of the technology company’s stock valued at $60,000 after buying an additional 770 shares in the last quarter. Allworth Financial LP lifted its position in shares of Koninklijke Philips by 113.3% in the third quarter. Allworth Financial LP now owns 3,242 shares of the technology company’s stock worth $65,000 after buying an additional 1,722 shares during the last quarter. Finally, Spire Wealth Management boosted its stake in shares of Koninklijke Philips by 127.2% during the 3rd quarter. Spire Wealth Management now owns 3,446 shares of the technology company’s stock worth $69,000 after acquiring an additional 1,929 shares in the last quarter. Institutional investors and hedge funds own 13.67% of the company’s stock.
Koninklijke Philips Company Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Further Reading
- Five stocks we like better than Koninklijke Philips
- What Are Trending Stocks? Trending Stocks Explained
- Celsius Stock’s Post-Earnings Morning Dip, Better than Coffee
- Industrial Products Stocks Investing
- Chegg Chokes on AI Attempt, CEO Talks it Up As He Passes Torch
- What is the S&P 500 and How It is Distinct from Other Indexes
- Does Logitech’s EPS Beat Signal the Rebound of Video Gaming?
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.